Comparison

Proloquo vs NeoCardioLab

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Proloquo

This app provides an intuitive and efficient Augmentative and Alternative Communication (AAC) solution for users of all ages. It facilitates language development and effective communication with features like quick access to words, a search function, and a unique Thinking Space for early communicators. It also offers a full keyboard with word prediction and expert guidance through an accompanying coach.

Highlights
  • Intuitive and easy-to-use interface
  • Quick access to frequently used words
  • Search function for effortless word finding
  • Focus Mode™ for targeted word emphasis
  • Thinking Space™ for early communicators (iPad only)
  • Extensive vocabulary with Related Words™
  • Full keyboard with word prediction
  • Proloquo Coach for expert guidance
Features
Read full description

AssistiveWare Proloquo is an intuitive, easy-to-use Augmentative and Alternative Communication (AAC) app. Based on years of research, it is the only AAC app designed to meet the needs of all ages without sacrificing ease of use or efficiency. Proloquo is more than just a communication tool; it’s a gateway to language development and effective communication. AN EASY START With a unique design and quick one-tap access to the most used words, you can start using AAC right away. Finding any word is effortless, with an easily accessible Search function. Need to focus on or teach specific words? Use Focus Mode™ and draw attention without restricting or deleting words. THINKING SPACE (only available on iPad) Understanding a beginning communicator can feel like an endless guessing game, leading to frustration on both sides. Proloquo’s unique Thinking Space™ feature allows you to visualize and explore thoughts and meaning even with the earliest communicators. Arrange Proloquo’s visuals in any order for more intuitive communication. Understand each other faster and easier with Proloquo’s Thinking Space. GROWS WITH YOU Proloquo offers an extensive vocabulary unmatched in size and efficiency. With a user-friendly interface and innovative features such as Related Words™, Proloquo ensures everyone, from toddlers to adults, can discover, learn, and love language. Proloquo also offers a full keyboard with word prediction to support literacy. GET EXPERT AAC GUIDANCE WITH PROLOQUO COACH We know learning AAC can be challenging - that’s why we paired Proloquo with Proloquo Coach. Free with a Proloquo subscription, it equips families and educators with the tools and knowledge needed to support children and students in learning to communicate using AAC. With fast in-app support and guided practice, you will always know what to do next. SHARE PROLOQUO WITH YOUR TEAM FOR FREE Share Proloquo at no additional cost. Involve teachers, Speech Pathologists, and grandparents - download the Proloquo app and sync across multiple devices for free. Try Proloquo free for one month! How payment works • After your trial ends, payment will be charged to your Apple Account. • Subscriptions renew automatically. Payment is charged 24 hours before the current subscription period ends. • Don’t want to renew? Cancel more than 24 hours before the end of the current subscription period. • Want to cancel or change your subscription? Manage it in your account settings on the App Store. The standard Apple Terms of Use apply to this app: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

About

NeoCardioLab

This app offers extensive educational content on neonatal hemodynamics and cardiovascular research. It provides learning modules, video clips, and an atlas for understanding echocardiography, POCUS, and congenital heart defects.

Highlights
  • Neonatal hemodynamics education
  • Echocardiography (2D & 3D) modules
  • Targeted Neonatal Echocardiography (TnECHO)
  • Point of Care Ultrasound (POCUS) training
  • Near Infrared Spectroscopy (NIRS) modules
  • Congenital heart defect resources
  • Research updates and webinars
Features
Read full description

The NeoCardioLab is a research laboratory interested in clinical and epidemiological neonatal cardiovascular research, as well as education in neonatal hemodynamics. The principal investigator of the NeoCardioLab is Dr. Gabriel Altit from the Montreal Children’s Hospital (at McGill University). On the NeoCardioLab website, we have made available for the learners a whole array of content (clips, videos, presentations, reading material, articles, etc.) as a learning opportunity on echocardiography (2D and 3D), TnECHO (targeted neonatal echocardiography), point of care ultrasound (POCUS) and near infrared spectroscopy (NIRS). You will find on the website, our comprehensive “Atlas” for the expected normal complete neonatal echocardiography (with clips of various views and explanations), as well as clips for selected congenital heart defects. Our training modules are: on NIRS in the neonatal intensive care unit, as well as on POCUS/TnECHO. We offer modules on TnECHO (Targeted Neonatal Echocardiography; with clips outlining all the views and measurements, pulmonary hypertension, PDA, normative values, etc.), POCUS (as well as the example of the use of a hand-held device and how to obtain views) and Congenital Heart defects, as well as modules on Strain/Speckle Tracking and Near Infrared Spectroscopy. We also now host the Neonatal NIRS consortium page and all the recordings of their webinars. Please feel free to navigate the app and use it for training purposes and as a resource to complement your other learning materials. We are constantly updating the website and adding new content. You will also find information on the McGill University Neonatal Hemodynamics Clinical Research training program, if you are interested. Our research uses conventional and advanced echocardiography (speckle-tracking echocardiography on 2D and 3D acquisitions) to better understand the cardiovascular adaptation of newborns with various conditions (such as: prematurity, bronchopulmonary dysplasia, congenital heart defect, congenital diaphragmatic hernia, omphalocele and hypoxic ischemic encephalopathy). We also study cohorts of patients once they have graduated the neonatal intensive care unit (in neonatal follow-up, in the pediatric clinics, as well as during adulthood). Please feel free to contact us if you have questions or suggestions: info@neocardiolab.com. We also have Twitter (@CardioNeo) and Instagram (@NeoCardioLab).

Screenshots

Proloquo4 screens
NeoCardioLab4 screens

Verdict

The call

The clearest difference is review sentiment: NeoCardioLab at 100% against Proloquo's 48%. NeoCardioLab also leads on rating (5.0 vs 3.9) and in-app purchases (none vs 6). Proloquo's advantage is ratings volume (143 vs 5). On price, ads and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Proloquo sells 6 in-app purchases, starting at $9.99 per month. NeoCardioLab asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

NeoCardioLab holds the better App Store score, 5.0 against 3.9. That said, the two scores are not equally well evidenced: Proloquo has 143 ratings behind it against 5, so its average is the more settled of the two. Written reviews point the same way: 48% of Proloquo's written reviews are positive against 100% of NeoCardioLab's.

UpkeepUpdate frequency

Proloquo ships an update every 6 weeks, NeoCardioLab weekly. The most recent releases landed on September 20, 2026 and June 5, 2026 respectively.

Scorecard7 real differences · 3 level
Proloquo versus NeoCardioLab: the parameters behind the verdict, then further details
ParameterProloquoNeoCardioLab
PriceFreeFree
Rating3.9 (143 ratings)5.0 (5 ratings) — better
Positive reviews48.4% of reviews100.0% of reviews — better
Number of ratings143 — better5
Update frequencyEvery 6 weeksWeekly — better
AdsNoNo
In-app purchasesYesNo — better
MonetizationSubscriptionFree — better
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS18.013.0 — better
Further details — not scored
Size503 MB35 MB
Age rating4+17+
DeveloperAssistiveWaregabriel altit

Customer experience

Proloquo

All ratings143 ratings
Positive70.6%
Neutral6.3%
Negative23.1%
Written reviews64 reviews
Positive48.4%
Neutral9.4%
Negative42.2%

NeoCardioLab

All ratings5 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

6 purchases

Proloquo

Subscriptions6
  • Monthly Subscription1 Month trial$9.991 Month
  • Monthly Subscription1 Year trial$9.991 Month
  • Monthly Subscription6 Months trial$9.991 Month
Show 3 more
  • Yearly Subscription1 Month trial$99.991 Year
  • Yearly Subscription1 Year trial$99.991 Year
  • Yearly Subscription6 Months trial$99.991 Year
None

NeoCardioLab

No in-app purchases

Questions

Is Proloquo free?
Proloquo is free to download, with in-app purchases available.
Is NeoCardioLab free?
NeoCardioLab is free to download, with no in-app purchases.
Which has better reviews, Proloquo or NeoCardioLab?
NeoCardioLab is rated higher. Proloquo averages 3.9 out of 5 from 143 ratings, while NeoCardioLab averages 5.0 from 5 ratings.
Do Proloquo or NeoCardioLab have ads?
Neither Proloquo nor NeoCardioLab shows ads.
Which is updated more often, Proloquo or NeoCardioLab?
Proloquo ships an update every 6 weeks, and NeoCardioLab weekly. Most recently, Proloquo was updated on September 20, 2026 and NeoCardioLab on June 5, 2026.

Other comparisons